Therefore, some authors studied the effect of GHRH antagonists on cell adhesion, observing a 34% reduction compared to control following treatment with MIA-602 in breast cancer, glioblastoma, and ovarian cancer cells [24]. Here, GHRH is linked to breast carcinoma.